PHARMACOKINETICS OF ORAL PROCYSTEINE EFFECTS ON GLUTATHIONE

口服半胱氨酸对谷胱甘肽作用的药代动力学

• 批准号: 3785442
• 负责人: MICHAEL M LEDERMAN
• 金额: --
• 依托单位: UNIVERSITY HOSPITALS OF CLEVELAND
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3785442
• 关键词: HIV infections; antiAIDS agent; drug quality /standard; glutathione; human subject; human therapy evaluation; oral administration; pharmacokinetics; placebos

The purposes of this placebo controlled phase I study are to determine the safety of Procysteine and to determine the levels of Procysteine, cysteine and glutathione after single oral doses and chronic administration of Procysteine.

本安慰剂对照I期研究的目的是确定 半胱氨酸原的安全性和确定半胱氨酸原的水平， 单次口服给药后半胱氨酸和谷胱甘肽， 给予半胱氨酸。